- Home
- Publications
- Publication Search
- Publication Details
Title
New advances in the treatments of drug-resistant tuberculosis
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 21, Issue 8, Pages 863-870
Publisher
Informa UK Limited
Online
2023-07-21
DOI
10.1080/14787210.2023.2240022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug resistant TB – latest developments in epidemiology, diagnostics and management
- (2022) Simon Tiberi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- High-performance immune diagnosis of tuberculosis: Use of phage display and synthetic peptide in an optimized experimental design
- (2022) Natália Notto Serena et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Comprehensive genomic analysis of Mycobacterium tuberculosis reveals limited impact of high-fitness genotypes on MDR-TB transmission
- (2022) Yiwang Chen et al. JOURNAL OF INFECTION
- Paving the way for phage therapy using novel drug delivery approaches
- (2022) Thomas Briot et al. JOURNAL OF CONTROLLED RELEASE
- Bedaquiline and Linezolid improve anti-TB treatment outcome in drug-resistant TB patients with HIV: A systematic review and meta-analysis
- (2022) Yaxin Wu et al. PHARMACOLOGICAL RESEARCH
- A CRISPR-guided mutagenic DNA polymerase strategy for the detection of antibiotic-resistant mutations in M. tuberculosis
- (2022) Siyuan Feng et al. Molecular Therapy-Nucleic Acids
- Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic
- (2021) Simon Tiberi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs
- (2021) Aditi Chauhan et al. LIFE SCIENCES
- A Phage Therapy Guide for Clinicians and Basic Scientists: Background and Highlighting Applications for Developing Countries
- (2021) Ali Khalid et al. Frontiers in Microbiology
- Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains
- (2021) Carlos A. Guerrero-Bustamante et al. mBio
- New Perspectives in Drug Delivery Systems for the Treatment of Tuberculosis
- (2021) Joandra Maísa da Silva Leite et al. CURRENT MEDICINAL CHEMISTRY
- CRISPR-based diagnostics
- (2021) Michael M. Kaminski et al. Nature Biomedical Engineering
- Mycobacteriophages to Treat Tuberculosis: Dream or Delusion?
- (2021) Andreas H. Diacon et al. RESPIRATION
- MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
- (2020) Giovanni Battista Migliori et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Novel Approach for Transdermal Delivery of Rifampicin to Induce Synergistic Antimycobacterial Effects Against Cutaneous and Systemic Tuberculosis Using a Cationic Nanoemulsion Gel
- (2020) Afzal Hussain et al. International Journal of Nanomedicine
- Nanotheranostics: Their role in hepatocellular carcinoma
- (2020) Rama Rao Malla et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Transdermal delivery of isoniazid loaded elastic liposomes to control cutaneous and systemic tuberculosis
- (2020) Mohammad A. Altamimi et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Three promising antimycobacterial medicinal plants reviewed as potential sources of drug hit candidates against multidrug-resistant tuberculosis
- (2020) Naasson Tuyiringire et al. TUBERCULOSIS
- Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
- (2019) Qiaoqiao Xiao et al. Frontiers in Cellular and Infection Microbiology
- Improving treatment outcomes for MDR-TB — Novel host-directed therapies and personalised medicine of the future
- (2019) Martin Rao et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
- (2019) Bin Liu et al. DRUG DISCOVERY TODAY
- Formulation and optimization of long acting dual niosomes using Box-Behnken experimental design method for combinative delivery of Ethionamide and D-cycloserine in Tuberculosis treatment
- (2019) Pratik Kulkarni et al. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
- The Mycobacterium tuberculosis CRISPR-Associated Cas1 Involves Persistence and Tolerance to Anti-Tubercular Drugs
- (2019) Jiawei Wei et al. Biomed Research International
- Prospects for the Use of New Technologies to Combat Multidrug-Resistant Bacteria
- (2019) Renata Lima et al. Frontiers in Pharmacology
- Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29
- (2019) Nicholas B. Carrigy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bedaquiline for the Treatment of Multidrug-Resistant Tuberculosis in the United States
- (2019) Sundari Mase et al. CLINICAL INFECTIOUS DISEASES
- Machine Learning Predicts Accurately Mycobacterium tuberculosis Drug Resistance From Whole Genome Sequencing Data
- (2019) Wouter Deelder et al. Frontiers in Genetics
- Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review
- (2019) Taher Azimi et al. Infection and Drug Resistance
- Recent updates on drug resistance in Mycobacterium tuberculosis
- (2019) R. Singh et al. JOURNAL OF APPLIED MICROBIOLOGY
- Recent advances in untargeted and targeted approaches applied in herbal-extracts and essential-oils fingerprinting - A review
- (2019) Mourad Kharbach et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Delivering CRISPR: a review of the challenges and approaches
- (2018) Christopher A. Lino et al. DRUG DELIVERY
- Development and biological evaluation of a new nanotheranostic for tuberculosis
- (2018) Edward Helal-Neto et al. Drug Delivery and Translational Research
- Drug resistance mechanisms and novel drug targets for tuberculosis therapy
- (2017) Md Mahmudul Islam et al. Journal of Genetics and Genomics
- Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?
- (2017) Keertan Dheda et al. RESPIROLOGY
- Inhalation Study of Mycobacteriophage D29 Aerosol for Mice by Endotracheal Route and Nose-Only Exposure
- (2016) Ke-yang Liu et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Pulmonary delivery of rifampicin microspheres using lower generation polyamidoamine dendrimers as a carrier
- (2016) Saeid Rajabnezhad et al. POWDER TECHNOLOGY
- Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): A systematic review of randomised clinical trials
- (2015) Mei Wang et al. TUBERCULOSIS
- Antitubercular Activity and the Subacute Toxicity of (−)-Licarin A in BALB/c Mice: A Neolignan Isolated from Aristolochia taliscana
- (2013) Rosalba León-Díaz et al. ARCHIVES OF MEDICAL RESEARCH
- Phage in the diagnosis and treatment of tuberculosis
- (2012) Shuliang Guo Frontiers in Bioscience-Landmark
- Flourensia cernua: Hexane Extracts a Very Active Mycobactericidal Fraction from an Inactive Leaf Decoction against Pansensitive and PanresistantMycobacterium tuberculosis
- (2011) Gloria María Molina-Salinas et al. Evidence-based Complementary and Alternative Medicine
- Anti-tuberculosis activity of commonly used medicinal plants of south India
- (2011) A.Sivakumar Journal of Medicinal Plants Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started